Global Esketamine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Esketamine is a medication used as a general anesthetic and for treatment-resistant depression.
LPI (LP Information)' newest research report, the “Esketamine Industry Forecast” looks at past sales and reviews total world Esketamine sales in 2022, providing a comprehensive analysis by region and market sector of projected Esketamine sales for 2023 through 2029. With Esketamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Esketamine industry.
This Insight Report provides a comprehensive analysis of the global Esketamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Esketamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Esketamine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Esketamine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Esketamine.
The global Esketamine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Esketamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Esketamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Esketamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Esketamine players cover Merck, Medkoo, Endo International, Janssen Pharmaceutica and PFIZER, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Esketamine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Esketamine market?
What factors are driving Esketamine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Esketamine market opportunities vary by end market size?
How does Esketamine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Esketamine is a medication used as a general anesthetic and for treatment-resistant depression.
LPI (LP Information)' newest research report, the “Esketamine Industry Forecast” looks at past sales and reviews total world Esketamine sales in 2022, providing a comprehensive analysis by region and market sector of projected Esketamine sales for 2023 through 2029. With Esketamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Esketamine industry.
This Insight Report provides a comprehensive analysis of the global Esketamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Esketamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Esketamine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Esketamine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Esketamine.
The global Esketamine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Esketamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Esketamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Esketamine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Esketamine players cover Merck, Medkoo, Endo International, Janssen Pharmaceutica and PFIZER, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Esketamine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Oral Medications
- Injection
- Nasal Spray
- General Anesthetic
- Treatment-resistant Depression
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Medkoo
- Endo International
- Janssen Pharmaceutica
- PFIZER
What is the 10-year outlook for the global Esketamine market?
What factors are driving Esketamine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Esketamine market opportunities vary by end market size?
How does Esketamine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Esketamine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Esketamine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Esketamine by Country/Region, 2018, 2022 & 2029
2.2 Esketamine Segment by Type
2.2.1 Oral Medications
2.2.2 Injection
2.2.3 Nasal Spray
2.3 Esketamine Sales by Type
2.3.1 Global Esketamine Sales Market Share by Type (2018-2023)
2.3.2 Global Esketamine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Esketamine Sale Price by Type (2018-2023)
2.4 Esketamine Segment by Application
2.4.1 General Anesthetic
2.4.2 Treatment-resistant Depression
2.5 Esketamine Sales by Application
2.5.1 Global Esketamine Sale Market Share by Application (2018-2023)
2.5.2 Global Esketamine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Esketamine Sale Price by Application (2018-2023)
3 GLOBAL ESKETAMINE BY COMPANY
3.1 Global Esketamine Breakdown Data by Company
3.1.1 Global Esketamine Annual Sales by Company (2018-2023)
3.1.2 Global Esketamine Sales Market Share by Company (2018-2023)
3.2 Global Esketamine Annual Revenue by Company (2018-2023)
3.2.1 Global Esketamine Revenue by Company (2018-2023)
3.2.2 Global Esketamine Revenue Market Share by Company (2018-2023)
3.3 Global Esketamine Sale Price by Company
3.4 Key Manufacturers Esketamine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Esketamine Product Location Distribution
3.4.2 Players Esketamine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ESKETAMINE BY GEOGRAPHIC REGION
4.1 World Historic Esketamine Market Size by Geographic Region (2018-2023)
4.1.1 Global Esketamine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Esketamine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Esketamine Market Size by Country/Region (2018-2023)
4.2.1 Global Esketamine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Esketamine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Esketamine Sales Growth
4.4 APAC Esketamine Sales Growth
4.5 Europe Esketamine Sales Growth
4.6 Middle East & Africa Esketamine Sales Growth
5 AMERICAS
5.1 Americas Esketamine Sales by Country
5.1.1 Americas Esketamine Sales by Country (2018-2023)
5.1.2 Americas Esketamine Revenue by Country (2018-2023)
5.2 Americas Esketamine Sales by Type
5.3 Americas Esketamine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Esketamine Sales by Region
6.1.1 APAC Esketamine Sales by Region (2018-2023)
6.1.2 APAC Esketamine Revenue by Region (2018-2023)
6.2 APAC Esketamine Sales by Type
6.3 APAC Esketamine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Esketamine by Country
7.1.1 Europe Esketamine Sales by Country (2018-2023)
7.1.2 Europe Esketamine Revenue by Country (2018-2023)
7.2 Europe Esketamine Sales by Type
7.3 Europe Esketamine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Esketamine by Country
8.1.1 Middle East & Africa Esketamine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Esketamine Revenue by Country (2018-2023)
8.2 Middle East & Africa Esketamine Sales by Type
8.3 Middle East & Africa Esketamine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Esketamine
10.3 Manufacturing Process Analysis of Esketamine
10.4 Industry Chain Structure of Esketamine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Esketamine Distributors
11.3 Esketamine Customer
12 WORLD FORECAST REVIEW FOR ESKETAMINE BY GEOGRAPHIC REGION
12.1 Global Esketamine Market Size Forecast by Region
12.1.1 Global Esketamine Forecast by Region (2024-2029)
12.1.2 Global Esketamine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Esketamine Forecast by Type
12.7 Global Esketamine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Esketamine Product Portfolios and Specifications
13.1.3 Merck Esketamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Medkoo
13.2.1 Medkoo Company Information
13.2.2 Medkoo Esketamine Product Portfolios and Specifications
13.2.3 Medkoo Esketamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medkoo Main Business Overview
13.2.5 Medkoo Latest Developments
13.3 Endo International
13.3.1 Endo International Company Information
13.3.2 Endo International Esketamine Product Portfolios and Specifications
13.3.3 Endo International Esketamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Endo International Main Business Overview
13.3.5 Endo International Latest Developments
13.4 Janssen Pharmaceutica
13.4.1 Janssen Pharmaceutica Company Information
13.4.2 Janssen Pharmaceutica Esketamine Product Portfolios and Specifications
13.4.3 Janssen Pharmaceutica Esketamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Janssen Pharmaceutica Main Business Overview
13.4.5 Janssen Pharmaceutica Latest Developments
13.5 PFIZER
13.5.1 PFIZER Company Information
13.5.2 PFIZER Esketamine Product Portfolios and Specifications
13.5.3 PFIZER Esketamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 PFIZER Main Business Overview
13.5.5 PFIZER Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Esketamine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Esketamine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Esketamine by Country/Region, 2018, 2022 & 2029
2.2 Esketamine Segment by Type
2.2.1 Oral Medications
2.2.2 Injection
2.2.3 Nasal Spray
2.3 Esketamine Sales by Type
2.3.1 Global Esketamine Sales Market Share by Type (2018-2023)
2.3.2 Global Esketamine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Esketamine Sale Price by Type (2018-2023)
2.4 Esketamine Segment by Application
2.4.1 General Anesthetic
2.4.2 Treatment-resistant Depression
2.5 Esketamine Sales by Application
2.5.1 Global Esketamine Sale Market Share by Application (2018-2023)
2.5.2 Global Esketamine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Esketamine Sale Price by Application (2018-2023)
3 GLOBAL ESKETAMINE BY COMPANY
3.1 Global Esketamine Breakdown Data by Company
3.1.1 Global Esketamine Annual Sales by Company (2018-2023)
3.1.2 Global Esketamine Sales Market Share by Company (2018-2023)
3.2 Global Esketamine Annual Revenue by Company (2018-2023)
3.2.1 Global Esketamine Revenue by Company (2018-2023)
3.2.2 Global Esketamine Revenue Market Share by Company (2018-2023)
3.3 Global Esketamine Sale Price by Company
3.4 Key Manufacturers Esketamine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Esketamine Product Location Distribution
3.4.2 Players Esketamine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ESKETAMINE BY GEOGRAPHIC REGION
4.1 World Historic Esketamine Market Size by Geographic Region (2018-2023)
4.1.1 Global Esketamine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Esketamine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Esketamine Market Size by Country/Region (2018-2023)
4.2.1 Global Esketamine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Esketamine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Esketamine Sales Growth
4.4 APAC Esketamine Sales Growth
4.5 Europe Esketamine Sales Growth
4.6 Middle East & Africa Esketamine Sales Growth
5 AMERICAS
5.1 Americas Esketamine Sales by Country
5.1.1 Americas Esketamine Sales by Country (2018-2023)
5.1.2 Americas Esketamine Revenue by Country (2018-2023)
5.2 Americas Esketamine Sales by Type
5.3 Americas Esketamine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Esketamine Sales by Region
6.1.1 APAC Esketamine Sales by Region (2018-2023)
6.1.2 APAC Esketamine Revenue by Region (2018-2023)
6.2 APAC Esketamine Sales by Type
6.3 APAC Esketamine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Esketamine by Country
7.1.1 Europe Esketamine Sales by Country (2018-2023)
7.1.2 Europe Esketamine Revenue by Country (2018-2023)
7.2 Europe Esketamine Sales by Type
7.3 Europe Esketamine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Esketamine by Country
8.1.1 Middle East & Africa Esketamine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Esketamine Revenue by Country (2018-2023)
8.2 Middle East & Africa Esketamine Sales by Type
8.3 Middle East & Africa Esketamine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Esketamine
10.3 Manufacturing Process Analysis of Esketamine
10.4 Industry Chain Structure of Esketamine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Esketamine Distributors
11.3 Esketamine Customer
12 WORLD FORECAST REVIEW FOR ESKETAMINE BY GEOGRAPHIC REGION
12.1 Global Esketamine Market Size Forecast by Region
12.1.1 Global Esketamine Forecast by Region (2024-2029)
12.1.2 Global Esketamine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Esketamine Forecast by Type
12.7 Global Esketamine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Esketamine Product Portfolios and Specifications
13.1.3 Merck Esketamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Medkoo
13.2.1 Medkoo Company Information
13.2.2 Medkoo Esketamine Product Portfolios and Specifications
13.2.3 Medkoo Esketamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medkoo Main Business Overview
13.2.5 Medkoo Latest Developments
13.3 Endo International
13.3.1 Endo International Company Information
13.3.2 Endo International Esketamine Product Portfolios and Specifications
13.3.3 Endo International Esketamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Endo International Main Business Overview
13.3.5 Endo International Latest Developments
13.4 Janssen Pharmaceutica
13.4.1 Janssen Pharmaceutica Company Information
13.4.2 Janssen Pharmaceutica Esketamine Product Portfolios and Specifications
13.4.3 Janssen Pharmaceutica Esketamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Janssen Pharmaceutica Main Business Overview
13.4.5 Janssen Pharmaceutica Latest Developments
13.5 PFIZER
13.5.1 PFIZER Company Information
13.5.2 PFIZER Esketamine Product Portfolios and Specifications
13.5.3 PFIZER Esketamine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 PFIZER Main Business Overview
13.5.5 PFIZER Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Esketamine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Esketamine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral Medications
Table 4. Major Players of Injection
Table 5. Major Players of Nasal Spray
Table 6. Global Esketamine Sales by Type (2018-2023) & (K Units)
Table 7. Global Esketamine Sales Market Share by Type (2018-2023)
Table 8. Global Esketamine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Esketamine Revenue Market Share by Type (2018-2023)
Table 10. Global Esketamine Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Esketamine Sales by Application (2018-2023) & (K Units)
Table 12. Global Esketamine Sales Market Share by Application (2018-2023)
Table 13. Global Esketamine Revenue by Application (2018-2023)
Table 14. Global Esketamine Revenue Market Share by Application (2018-2023)
Table 15. Global Esketamine Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Esketamine Sales by Company (2018-2023) & (K Units)
Table 17. Global Esketamine Sales Market Share by Company (2018-2023)
Table 18. Global Esketamine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Esketamine Revenue Market Share by Company (2018-2023)
Table 20. Global Esketamine Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Esketamine Producing Area Distribution and Sales Area
Table 22. Players Esketamine Products Offered
Table 23. Esketamine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Esketamine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Esketamine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Esketamine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Esketamine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Esketamine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Esketamine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Esketamine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Esketamine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Esketamine Sales by Country (2018-2023) & (K Units)
Table 35. Americas Esketamine Sales Market Share by Country (2018-2023)
Table 36. Americas Esketamine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Esketamine Revenue Market Share by Country (2018-2023)
Table 38. Americas Esketamine Sales by Type (2018-2023) & (K Units)
Table 39. Americas Esketamine Sales by Application (2018-2023) & (K Units)
Table 40. APAC Esketamine Sales by Region (2018-2023) & (K Units)
Table 41. APAC Esketamine Sales Market Share by Region (2018-2023)
Table 42. APAC Esketamine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Esketamine Revenue Market Share by Region (2018-2023)
Table 44. APAC Esketamine Sales by Type (2018-2023) & (K Units)
Table 45. APAC Esketamine Sales by Application (2018-2023) & (K Units)
Table 46. Europe Esketamine Sales by Country (2018-2023) & (K Units)
Table 47. Europe Esketamine Sales Market Share by Country (2018-2023)
Table 48. Europe Esketamine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Esketamine Revenue Market Share by Country (2018-2023)
Table 50. Europe Esketamine Sales by Type (2018-2023) & (K Units)
Table 51. Europe Esketamine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Esketamine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Esketamine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Esketamine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Esketamine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Esketamine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Esketamine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Esketamine
Table 59. Key Market Challenges & Risks of Esketamine
Table 60. Key Industry Trends of Esketamine
Table 61. Esketamine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Esketamine Distributors List
Table 64. Esketamine Customer List
Table 65. Global Esketamine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Esketamine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Esketamine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Esketamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Esketamine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Esketamine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Esketamine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Esketamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Esketamine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Esketamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Esketamine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Esketamine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Esketamine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Esketamine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Esketamine Product Portfolios and Specifications
Table 81. Merck Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Medkoo Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 85. Medkoo Esketamine Product Portfolios and Specifications
Table 86. Medkoo Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Medkoo Main Business
Table 88. Medkoo Latest Developments
Table 89. Endo International Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 90. Endo International Esketamine Product Portfolios and Specifications
Table 91. Endo International Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Endo International Main Business
Table 93. Endo International Latest Developments
Table 94. Janssen Pharmaceutica Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 95. Janssen Pharmaceutica Esketamine Product Portfolios and Specifications
Table 96. Janssen Pharmaceutica Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Janssen Pharmaceutica Main Business
Table 98. Janssen Pharmaceutica Latest Developments
Table 99. PFIZER Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 100. PFIZER Esketamine Product Portfolios and Specifications
Table 101. PFIZER Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. PFIZER Main Business
Table 103. PFIZER Latest Developments
Table 1. Esketamine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Esketamine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral Medications
Table 4. Major Players of Injection
Table 5. Major Players of Nasal Spray
Table 6. Global Esketamine Sales by Type (2018-2023) & (K Units)
Table 7. Global Esketamine Sales Market Share by Type (2018-2023)
Table 8. Global Esketamine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Esketamine Revenue Market Share by Type (2018-2023)
Table 10. Global Esketamine Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Esketamine Sales by Application (2018-2023) & (K Units)
Table 12. Global Esketamine Sales Market Share by Application (2018-2023)
Table 13. Global Esketamine Revenue by Application (2018-2023)
Table 14. Global Esketamine Revenue Market Share by Application (2018-2023)
Table 15. Global Esketamine Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Esketamine Sales by Company (2018-2023) & (K Units)
Table 17. Global Esketamine Sales Market Share by Company (2018-2023)
Table 18. Global Esketamine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Esketamine Revenue Market Share by Company (2018-2023)
Table 20. Global Esketamine Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Esketamine Producing Area Distribution and Sales Area
Table 22. Players Esketamine Products Offered
Table 23. Esketamine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Esketamine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Esketamine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Esketamine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Esketamine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Esketamine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Esketamine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Esketamine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Esketamine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Esketamine Sales by Country (2018-2023) & (K Units)
Table 35. Americas Esketamine Sales Market Share by Country (2018-2023)
Table 36. Americas Esketamine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Esketamine Revenue Market Share by Country (2018-2023)
Table 38. Americas Esketamine Sales by Type (2018-2023) & (K Units)
Table 39. Americas Esketamine Sales by Application (2018-2023) & (K Units)
Table 40. APAC Esketamine Sales by Region (2018-2023) & (K Units)
Table 41. APAC Esketamine Sales Market Share by Region (2018-2023)
Table 42. APAC Esketamine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Esketamine Revenue Market Share by Region (2018-2023)
Table 44. APAC Esketamine Sales by Type (2018-2023) & (K Units)
Table 45. APAC Esketamine Sales by Application (2018-2023) & (K Units)
Table 46. Europe Esketamine Sales by Country (2018-2023) & (K Units)
Table 47. Europe Esketamine Sales Market Share by Country (2018-2023)
Table 48. Europe Esketamine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Esketamine Revenue Market Share by Country (2018-2023)
Table 50. Europe Esketamine Sales by Type (2018-2023) & (K Units)
Table 51. Europe Esketamine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Esketamine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Esketamine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Esketamine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Esketamine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Esketamine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Esketamine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Esketamine
Table 59. Key Market Challenges & Risks of Esketamine
Table 60. Key Industry Trends of Esketamine
Table 61. Esketamine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Esketamine Distributors List
Table 64. Esketamine Customer List
Table 65. Global Esketamine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Esketamine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Esketamine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Esketamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Esketamine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Esketamine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Esketamine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Esketamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Esketamine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Esketamine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Esketamine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Esketamine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Esketamine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Esketamine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Esketamine Product Portfolios and Specifications
Table 81. Merck Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Medkoo Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 85. Medkoo Esketamine Product Portfolios and Specifications
Table 86. Medkoo Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Medkoo Main Business
Table 88. Medkoo Latest Developments
Table 89. Endo International Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 90. Endo International Esketamine Product Portfolios and Specifications
Table 91. Endo International Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Endo International Main Business
Table 93. Endo International Latest Developments
Table 94. Janssen Pharmaceutica Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 95. Janssen Pharmaceutica Esketamine Product Portfolios and Specifications
Table 96. Janssen Pharmaceutica Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Janssen Pharmaceutica Main Business
Table 98. Janssen Pharmaceutica Latest Developments
Table 99. PFIZER Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 100. PFIZER Esketamine Product Portfolios and Specifications
Table 101. PFIZER Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. PFIZER Main Business
Table 103. PFIZER Latest Developments
LIST OF FIGURES
Figure 1. Picture of Esketamine
Figure 2. Esketamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Esketamine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Esketamine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Esketamine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral Medications
Figure 10. Product Picture of Injection
Figure 11. Product Picture of Nasal Spray
Figure 12. Global Esketamine Sales Market Share by Type in 2022
Figure 13. Global Esketamine Revenue Market Share by Type (2018-2023)
Figure 14. Esketamine Consumed in General Anesthetic
Figure 15. Global Esketamine Market: General Anesthetic (2018-2023) & (K Units)
Figure 16. Esketamine Consumed in Treatment-resistant Depression
Figure 17. Global Esketamine Market: Treatment-resistant Depression (2018-2023) & (K Units)
Figure 18. Global Esketamine Sales Market Share by Application (2022)
Figure 19. Global Esketamine Revenue Market Share by Application in 2022
Figure 20. Esketamine Sales Market by Company in 2022 (K Units)
Figure 21. Global Esketamine Sales Market Share by Company in 2022
Figure 22. Esketamine Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Esketamine Revenue Market Share by Company in 2022
Figure 24. Global Esketamine Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Esketamine Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Esketamine Sales 2018-2023 (K Units)
Figure 27. Americas Esketamine Revenue 2018-2023 ($ Millions)
Figure 28. APAC Esketamine Sales 2018-2023 (K Units)
Figure 29. APAC Esketamine Revenue 2018-2023 ($ Millions)
Figure 30. Europe Esketamine Sales 2018-2023 (K Units)
Figure 31. Europe Esketamine Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Esketamine Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Esketamine Revenue 2018-2023 ($ Millions)
Figure 34. Americas Esketamine Sales Market Share by Country in 2022
Figure 35. Americas Esketamine Revenue Market Share by Country in 2022
Figure 36. Americas Esketamine Sales Market Share by Type (2018-2023)
Figure 37. Americas Esketamine Sales Market Share by Application (2018-2023)
Figure 38. United States Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Esketamine Sales Market Share by Region in 2022
Figure 43. APAC Esketamine Revenue Market Share by Regions in 2022
Figure 44. APAC Esketamine Sales Market Share by Type (2018-2023)
Figure 45. APAC Esketamine Sales Market Share by Application (2018-2023)
Figure 46. China Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Esketamine Sales Market Share by Country in 2022
Figure 54. Europe Esketamine Revenue Market Share by Country in 2022
Figure 55. Europe Esketamine Sales Market Share by Type (2018-2023)
Figure 56. Europe Esketamine Sales Market Share by Application (2018-2023)
Figure 57. Germany Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Esketamine Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Esketamine Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Esketamine Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Esketamine Sales Market Share by Application (2018-2023)
Figure 66. Egypt Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Esketamine in 2022
Figure 72. Manufacturing Process Analysis of Esketamine
Figure 73. Industry Chain Structure of Esketamine
Figure 74. Channels of Distribution
Figure 75. Global Esketamine Sales Market Forecast by Region (2024-2029)
Figure 76. Global Esketamine Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Esketamine Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Esketamine Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Esketamine Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Esketamine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Esketamine
Figure 2. Esketamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Esketamine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Esketamine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Esketamine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral Medications
Figure 10. Product Picture of Injection
Figure 11. Product Picture of Nasal Spray
Figure 12. Global Esketamine Sales Market Share by Type in 2022
Figure 13. Global Esketamine Revenue Market Share by Type (2018-2023)
Figure 14. Esketamine Consumed in General Anesthetic
Figure 15. Global Esketamine Market: General Anesthetic (2018-2023) & (K Units)
Figure 16. Esketamine Consumed in Treatment-resistant Depression
Figure 17. Global Esketamine Market: Treatment-resistant Depression (2018-2023) & (K Units)
Figure 18. Global Esketamine Sales Market Share by Application (2022)
Figure 19. Global Esketamine Revenue Market Share by Application in 2022
Figure 20. Esketamine Sales Market by Company in 2022 (K Units)
Figure 21. Global Esketamine Sales Market Share by Company in 2022
Figure 22. Esketamine Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Esketamine Revenue Market Share by Company in 2022
Figure 24. Global Esketamine Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Esketamine Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Esketamine Sales 2018-2023 (K Units)
Figure 27. Americas Esketamine Revenue 2018-2023 ($ Millions)
Figure 28. APAC Esketamine Sales 2018-2023 (K Units)
Figure 29. APAC Esketamine Revenue 2018-2023 ($ Millions)
Figure 30. Europe Esketamine Sales 2018-2023 (K Units)
Figure 31. Europe Esketamine Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Esketamine Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Esketamine Revenue 2018-2023 ($ Millions)
Figure 34. Americas Esketamine Sales Market Share by Country in 2022
Figure 35. Americas Esketamine Revenue Market Share by Country in 2022
Figure 36. Americas Esketamine Sales Market Share by Type (2018-2023)
Figure 37. Americas Esketamine Sales Market Share by Application (2018-2023)
Figure 38. United States Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Esketamine Sales Market Share by Region in 2022
Figure 43. APAC Esketamine Revenue Market Share by Regions in 2022
Figure 44. APAC Esketamine Sales Market Share by Type (2018-2023)
Figure 45. APAC Esketamine Sales Market Share by Application (2018-2023)
Figure 46. China Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Esketamine Sales Market Share by Country in 2022
Figure 54. Europe Esketamine Revenue Market Share by Country in 2022
Figure 55. Europe Esketamine Sales Market Share by Type (2018-2023)
Figure 56. Europe Esketamine Sales Market Share by Application (2018-2023)
Figure 57. Germany Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Esketamine Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Esketamine Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Esketamine Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Esketamine Sales Market Share by Application (2018-2023)
Figure 66. Egypt Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Esketamine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Esketamine in 2022
Figure 72. Manufacturing Process Analysis of Esketamine
Figure 73. Industry Chain Structure of Esketamine
Figure 74. Channels of Distribution
Figure 75. Global Esketamine Sales Market Forecast by Region (2024-2029)
Figure 76. Global Esketamine Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Esketamine Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Esketamine Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Esketamine Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Esketamine Revenue Market Share Forecast by Application (2024-2029)
